Reprogramming T Cells And Reducing Manufacturing Costs With RegCell’s Michael McCullar, Ph.D.

The Editors’ Roundtable: A Midyear Look At The 2026 Life Sciences Industry

In this special edition of “Better Biopharma,” host Tyler Menichiello is joined by chief editors from across the Life Science Connect ecosystem to discuss what’s shaping the pharmaceutical industry in 2026. The editors reflect on recent developments in their respective spaces and make predictions on what the rest of the year has in store. They also highlight some exciting projects happening across their publications.  This roundtable features Katie Anderson [https://www.linkedin.com/in/katieanderson121/], chief editor at Pharmaceutical Online [https://www.pharmaceuticalonline.com/]; Jeff Buguliskis, Ph.D. [https://www.linkedin.com/in/jeffbuguliskis/], deputy chief editor at Outsourced Pharma [https://www.outsourcedpharma.com/]; Ben Comer [https://www.linkedin.com/in/bencomer/], chief editor at Life Science Leader [https://www.lifescienceleader.com/] and host of The Business Of Biotech [https://www.lifescienceleader.com/solution/the-business-of-biotech-podcast-lsl] podcast; Ray Dogum [https://www.linkedin.com/in/raydogum/], chief editor at Drug Discovery Online [https://www.drugdiscoveryonline.com/]; Rachel Grabenhofer [https://www.linkedin.com/in/rgrabenhofer/], chief editor at Clinical Supply Leader [https://www.clinicalsupplyleader.com/]; Erin Harris [https://www.linkedin.com/in/erinharris/], chief editor at Cell & Gene [https://www.cellandgene.com/] and host of Cell & Gene: The Podcast [https://www.cellandgene.com/solution/cell-gene-the-podcast]; Dan Schell [https://www.linkedin.com/in/schelldan/], chief editor at Clinical Leader [https://www.clinicalleader.com/]; and Anna Rose Welch [https://www.linkedin.com/in/annarosewelch/], chief editor at Advancing RNA [https://www.advancingrna.com/]. Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/ [https://www.bioprocessonline.com/] Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/ [https://www.linkedin.com/in/tmenichiello/] Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions [https://www.bioprocessonline.com/user/edit/subscriptions] Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header [https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header]

Validation Challenges Facing Advanced Single-Use Technologies

In this episode of "Better Biopharma," host Tyler Menichiello is joined by BioPlan Associates’ director of research, Katrina Cordovado, as well as Joshua Nelson, Ph.D., a senior material qualification specialist at Takeda, and Paul Priebe, a consultant and single-use expert, to continue their conversation from the Bioprocess Online Live event, "Closing The Adoption Gap For Advanced Single-Use Materials [https://www.bioprocessonline.com/doc/closing-the-adoption-gap-for-advanced-single-use-materials-0001]." Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/ [https://www.bioprocessonline.com/] Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/ [https://www.linkedin.com/in/tmenichiello/] Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions [https://www.bioprocessonline.com/user/edit/subscriptions] Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header [https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header]

Aligning Upstream And Downstream Development (Part 2)

In Part 2 of this conversation on “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration [https://www.bioprocessonline.com/doc/optimizing-process-development-through-upstream-and-downstream-integration-0001]” continue their discussion about how upstream and downstream development teams can work together to accelerate timelines and reduce risk and bottlenecks in process development. Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/ [https://www.bioprocessonline.com/] Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/ [https://www.linkedin.com/in/tmenichiello/] Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions [https://www.bioprocessonline.com/user/edit/subscriptions] Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header [https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header]

Aligning Upstream And Downstream Development (Part 1)

In this episode of “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration [https://www.bioprocessonline.com/doc/optimizing-process-development-through-upstream-and-downstream-integration-0001]” continue their conversation about how upstream and downstream development teams can work together to accelerate timelines and reduce risks and bottlenecks in process development. Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/ [https://www.bioprocessonline.com/] Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/ [https://www.linkedin.com/in/tmenichiello/] Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions [https://www.bioprocessonline.com/user/edit/subscriptions] Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header [https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header]

Reprogramming T Cells And Reducing Manufacturing Costs With RegCell’s Michael McCullar, Ph.D.

In this episode of “Better Biopharma,” host Tyler Menichiello speaks with Michael McCullar, Ph.D., CEO at RegCell, a cell-therapy company developing regulatory T cell (Treg) therapies for autoimmune diseases. They discuss RegCell’s origins and its disease-agnostic approach to product development, as well as the ongoing efforts to improve the commercial viability of cell therapies by reducing manufacturing costs through automation and point-of-care models. Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/ [https://www.bioprocessonline.com/] Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/ [https://www.linkedin.com/in/tmenichiello/] Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions [https://www.bioprocessonline.com/user/edit/subscriptions] Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header [https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header]